Regulation of Interleukin-12 Production in Human Cells Stimulated withMycobacterium bovisBCG

This publication has 18 references indexed in Scilit:

• Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
  European Journal of Immunology, 1994
• Interleukin 12 at the site of disease in tuberculosis.
  Journal of Clinical Investigation, 1994
• Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
  International Journal of Epidemiology, 1993
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
  The Journal of Experimental Medicine, 1993
• Interleukin-12 and its role in the generation of TH1 cells
  Immunology Today, 1993
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
  The Journal of Experimental Medicine, 1992
• Macrophage deactivation by interleukin 10.
  The Journal of Experimental Medicine, 1991
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991